{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:55:41Z","timestamp":1790898941701,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"DOI":"10.1007\/s11739-026-04541-5","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:06:40Z","timestamp":1790852800000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Angiotensin receptor\u2013neprilysin inhibitor versus angiotensin-converting enzyme inhibitor for osteoporosis risk in patients with heart failure"],"prefix":"10.1007","author":[{"given":"Wei-Syun","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chieh","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"4541_CR1","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2024.39","volume":"11","author":"M Iacoviello","year":"2025","unstructured":"Iacoviello M, Maria Sarullo F, Bilato C, Correale M, Di Gesaro G, Driussi M, Passantino A, Villani A, Di Lenarda A (2025) Improving the management of patients with heart failure with reduced ejection fraction in clinical practice: the case for angiotensin receptor-neprilysin inhibitor. Card Fail Rev 11:e16. https:\/\/doi.org\/10.15420\/cfr.2024.39","journal-title":"Card Fail Rev"},{"issue":"2","key":"4541_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.36628\/ijhf.2020.0002","volume":"2","author":"B Greenberg","year":"2020","unstructured":"Greenberg B (2020) Angiotensin receptor-neprilysin inhibition (ARNI) in heart failure. Int J Heart Fail 2(2):73\u201390","journal-title":"Int J Heart Fail"},{"issue":"3","key":"4541_CR3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3904\/kjim.2020.105","volume":"35","author":"HM Choi","year":"2020","unstructured":"Choi HM, Shin MS (2020) Angiotensin receptor-neprilysin inhibitor for the treatment of heart failure: a review of recent evidence. Korean J Intern Med 35(3):498\u2013513","journal-title":"Korean J Intern Med"},{"issue":"4","key":"4541_CR4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s11914-012-0115-2","volume":"10","author":"AO Aluoch","year":"2012","unstructured":"Aluoch AO, Jessee R, Habal H, Garcia-Rosell M, Shah R, Reed G, Carbone L (2012) Heart failure as a risk factor for osteoporosis and fractures. Curr Osteoporos Rep 10(4):258\u2013269","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"4541_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/jcdd12020069","volume":"12","author":"R Spoladore","year":"2025","unstructured":"Spoladore R, Ciampi CM, Ossola P, Sultana A, Spreafico LP, Farina A, Fragasso G (2025) Heart failure and osteoporosis: shared challenges in the aging population. Rev J Cardiovasc Dev Dis 12(2):69","journal-title":"Rev J Cardiovasc Dev Dis"},{"key":"4541_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-025-10092-w","author":"AJ Chang","year":"2026","unstructured":"Chang AJ, Go AS, Chandra M, Carbone LD, Fink HA, Ott SM, Lo JC (2026) Heart failure is an independent risk factor for incident hip, proximal humerus, and wrist fractures in a high-risk older population. J Gen Intern Med. https:\/\/doi.org\/10.1007\/s11606-025-10092-w","journal-title":"J Gen Intern Med"},{"issue":"2","key":"4541_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/jcsm.12516","volume":"11","author":"G Loncar","year":"2020","unstructured":"Loncar G, Cvetinovic N, Lainscak M, Isakovi\u0107 A, von Haehling SJ (2020) Bone in heart failure. Cachexia Sarcopenia Muscle 11(2):381\u2013393","journal-title":"Cachexia Sarcopenia Muscle"},{"issue":"1","key":"4541_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1524-6175.2007.6359.x","volume":"9","author":"DA Sica","year":"2007","unstructured":"Sica DA (2007) Combination ACE inhibitor and angiotensin receptor blocker therapy\u2014future considerations. Rev J Clin Hypertens (Greenwich) 9(1):78\u201386","journal-title":"Rev J Clin Hypertens (Greenwich)"},{"issue":"9","key":"4541_CR9","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1177\/10600280241282324","volume":"59","author":"K Shah","year":"2025","unstructured":"Shah K, Mabhugu S, Obioma J, Nguyen Q, Schillig J, Torres BP, Howard M, Lindley B (2025) Angiotensin-converting enzyme inhibitor washout period prior to angiotensin receptor\/neprilysin inhibitor initiation in the inpatient setting. Ann Pharmacother 59(9):835\u2013838","journal-title":"Ann Pharmacother"},{"issue":"1","key":"4541_CR10","first-page":"57","volume":"46","author":"T Kwok","year":"2017","unstructured":"Kwok T, Leung J, Barrett-Connor E, Osteoporotic Fractures in Men (MrOS) Research Group (2017) ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men. Obs Study Age Ageing 46(1):57\u201364","journal-title":"Obs Study Age Ageing"},{"key":"4541_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2025.117710","volume":"203","author":"D Fitzpatrick","year":"2026","unstructured":"Fitzpatrick D, Laird E, Ward M, Hoey L, Hughes CF, McAnena L, Strain JJ, Cunningham C, Molloy AM, McNulty H, Lannon R, McCarroll K (2026) Angiotensin receptor blockers (ARBs) but not angiotensin-converting enzyme inhibitors (ACE-Is) are associated with lower osteoclast activity and higher bone mineral density: results from the TUDA study. Bone 203:117710","journal-title":"Bone"},{"key":"4541_CR12","unstructured":"National Health Research Institutes. National Health Insurance research database. http:\/\/nhird.nhri.org.tw\/en\/index.html. Accessed 14 Apr 2015"},{"issue":"8","key":"4541_CR13","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.029565","volume":"12","author":"S Tsukamoto","year":"2023","unstructured":"Tsukamoto S, Uehara T, Azushima K, Wakui H, Tamura K (2023) Updates for cardio-kidney protective effects by angiotensin receptor-neprilysin inhibitor: requirement for additional evidence of kidney protection. Rev J Am Heart Assoc 12(8):e029565","journal-title":"Rev J Am Heart Assoc"},{"issue":"9","key":"4541_CR14","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1002\/ejhf.1976","volume":"22","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan M, McMurray JJV, Solomon SD (2020) Angiotensin receptor-neprilysin inhibition in heart failure with preserved ejection fraction: lessons from PARAGON-HF. Eur J Heart Fail 22(9):1525\u20131530","journal-title":"Eur J Heart Fail"},{"key":"4541_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.940654","volume":"13","author":"C Cloro","year":"2022","unstructured":"Cloro C, Zaffina I, Sacchetta L, Arturi F, Clausi C, Luc\u00e0 S, Pelle MC, Giofr\u00e8 F, Armentaro G, Forte V, Rosa FMD, Sciacqua A, Arturi F (2022) Effects of sacubitril\/valsartan on both metabolic parameters and insulin resistance in prediabetic non-obese patients with heart failure and reduced ejection fraction. Front Endocrinol (Lausanne) 13:940654","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4541_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.684375","volume":"12","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Wang C, Xu Y, Wang X, Jia B, Yu T, Wang Y, Zhang Y (2021) Effects of the local bone renin-angiotensin system on titanium-particle-induced periprosthetic osteolysis. Front Pharmacol 12:684375","journal-title":"Front Pharmacol"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04541-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-026-04541-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04541-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:23:31Z","timestamp":1790897011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-026-04541-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":16,"alternative-id":["4541"],"URL":"https:\/\/doi.org\/10.1007\/s11739-026-04541-5","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"28 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"For this type of study formal consent is not required.","order":1,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","label":"Human and animal rights statement","group":{"name":"EthicsHeading","label":"Declarations"}}]}}